Randomized, double-blind, placebo-controlled, parallel-group, multi-centered, outpatient study to assess the efficacy, safety and tolerability of two doses of nalmefene in patients with current diagnosis of pathological gambling.
The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.